Navigation Links
Stemedica Announces the Appointment of Dr. Lev Verkh as Chief Regulatory and Clinical Development Officer
Date:6/13/2010

Stemedica announced today the appointment of Lev Verkh, PhD as Chief Regulatory and Clinical Development Officer. Dr. Verkh will be responsible for managing all regulatory activities and clinical trials on behalf of the company.

(PRWEB) June 11, 2010 -- Stemedica Cell Technologies, Inc., a leader in adult stem cell research and manufacturing, announced today the appointment of Lev Verkh, PhD as Chief Regulatory and Clinical Development Officer. Dr. Verkh will be responsible for managing all regulatory activities and clinical trials on behalf of the company. "Dr. Verkh brings over twenty years of international regulatory and clinical trial experience to Stemedica," said Dr. Nikolai Tankovich, Stemedica's President & Chief Medical Officer. "We are confident that his contribution to our mission to bring innovative products to patients, following FDA guidelines, will be significant."

Dr. Verkh's clinical and regulatory experience includes working for Pfizer, Baxter Bio Sciences, the Alliance Pharmaceutical Corporation and the Alpha Therapeutic Corporation. He has directed national and multi-national Phase I, II, III and IV clinical trials in such areas as cardiology, oncology, peripheral artery disease, hematology, blood disorders and imaging methods. He is author or co-author of over 40 peer-reviewed publications. Through his efforts and the efforts of his teams, he has received FDA approval for several products that are currently on the market. "I am honored to be joining Stemedica's management team," said Dr. Verkh, "and am excited to work with the company's leading-edge stem cell technology."

In addition to directing Stemedica's clinical trials within the United States, Dr.
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2

Related biology technology :

1. Stemedica Completes Meeting with the FDA
2. United States Patent and Trademark Office Publishes Stemedica's Patent Application for the Treatment of Diabetic Retinopathy
3. The Jordanian Stem Cell Company Acquires Stem Cell Technology From Stemedica International S.A. - First Clinical Trail Anticipated To Begin Early 2010
4. Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
5. Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries
6. Stemedica Requests Pre-IND Meeting With FDA
7. Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher
8. Renowned Stem Cell Researcher Files Study Results With Stemedica
9. CIRM Completes Briefing Visit to Stemedica Cell Technologies
10. Stemedica Announces the Appointment of Dr. Michael Bayer as Director, Medical Services
11. Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stemedica Announces the Appointment of Dr. Lev Verkh as Chief Regulatory and Clinical Development Officer 
(Date:5/21/2013)... , May 21, 2013  Synthetic Biologics, Inc. (NYSE MKT: ... treatment of serious infectious diseases, announced today that ... nd Annual Marcum LLP MicroCap Conference on Thursday, May ... at the Grand Hyatt Hotel. Mr. Riley is scheduled to ... webcast of Synthetic Biologics, presentation can be accessed by logging ...
(Date:5/21/2013)... Bed bugs have become so widespread in ... many turn to chemical-based pesticides for help to completely get ... risks those solutions present, the company advised the public to ... , According to My Cleaning Products, chemical-based pesticides are ... be. It shared that the pests have already developed immunity ...
(Date:5/21/2013)... NANONEX CORPORATION, a pioneer and leading company ... successful delivery and installation of a new nanoimprint ... major Japanese manufacturing company. , ... lithography tool that has the ability to process ... types. Based on Nanonex inventions and proprietary technologies, ...
(Date:5/21/2013)... May 21, 2013 Vital Imaging ... University of California, San Diego for a joint study ... Gravitic™ MRI (Magnetic Resonance Imaging) with that of a ... its continued pursuit of improved healthcare by combining cutting ... is an extremely valuable tool for evaluating pathological changes ...
Breaking Biology Technology:Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2Vital Imaging Makes Greater Commitment into MRI Research 2Vital Imaging Makes Greater Commitment into MRI Research 3
... U.S. HIV/AIDS Patients Live in States Now Providing ... Medicaid Coverage ... ,Monogram Biosciences, Inc. (Nasdaq: MGRM ) today announced that ... a diagnostic used to determine patient candidacy for Pfizer,s new,HIV ...
... or drop of liquid and the shape of the surface ... formula published this week in Physical Review Letters. , ... for a number of areas, including the chemical industry and ... explain how the relationship between the liquid and the surface ...
... in Europe ... expertise., BOSTON, April 7, 2008 The company is ... based in the United,Kingdom. Penny will work closely with US ... European and global,business. Penny specializes in the provision of actionable ...
Cached Biology Technology:New York Medicaid Program Establishes Coverage for Trofile(TM) 2New York Medicaid Program Establishes Coverage for Trofile(TM) 3New York Medicaid Program Establishes Coverage for Trofile(TM) 4Physicists saved from drowning in complexities of wetting theory 2Observant LLC Appoints Two New Directors to the Senior Management Team 2
(Date:5/21/2013)... Researchers at USC have found that a class of ... mice. , The drugs, known as "TSPO ligands," ... "We looked at the effects of TSPO ligand in ... stage, and in aged mice when pathology was quite ... Davis School of Gerontology. "TSPO ligand reduced measures of ...
(Date:5/21/2013)... College of Medicine will study gender differences in how the ... -- and how changes in fat metabolism play a role ... from the National Heart, Lung and Blood Institute. , When ... These changes may play a major role in the development ... says E. Douglas Lewandowski, director of the UIC Center for ...
(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
... VistaGen Therapeutics and the Wisconsin Alumni Research Foundation (WARF) ... patents for the development and commercialization of stem cell-based ... South San Francisco, is one of the world,s leading ... technology to transform the ways drugs are discovered and ...
... straightforward experiment, researchers have provided some clues to one ... came together to form the basis of life. ... JBC , demonstrated how ancient RNA joined together ... single-stranded precursor to DNA, normally expands one nucleic base ...
... Dec 18, 2008 Those ferocious Hollywood meat-eating dinosaurs ... had a much softer side: the males might even ... far-flung study conducted by a Texas A&M University researcher. ... Geology and Geophysics, and team members from Montana State ...
Cached Biology News:VistaGen, WARF sign license agreement for human embryonic stem cell technology 2Male dinosaurs may have been prehistoric babysitters, study shows 2
Homo sapiens postsynaptic protein CRIPT Antigen: Recombinant Protein...
... The high-performance triple quadrupole 1200L ... in today's cost-conscious environment - incorporating ... solutions for all liquid chromatography analytical ... (API) interface and the Transmission Quadrupole ...
Human Legumain Affinity Purified Polyclonal Ab...
Mouse Endoglin/CD105 Fluorescein MAb (Clone 209701)...
Biology Products: